| Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
| Diurnal Group Plc |
LSE:DNL |
London |
Ordinary Share |
GB00BDB6Q760 |
ORD GBP0.05 |
| |
Price Change |
% Change |
Share Price |
Shares Traded |
Last Trade |
| |
0.00 |
0.0% |
10.75 |
30,000 |
08:00:00 |
| Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
|
10.50
|
11.00
|
10.75 |
10.75 |
10.75 |
| Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
|
Pharmaceuticals & Biotechnology
|
4.37
|
-11.54
|
-7.30
|
|
18
|
| Last Trade Time |
Trade Type |
Trade Size |
Trade Price |
Currency |
| 08:12:19 |
O |
10,000 |
10.50 |
GBX |
| Trade Time |
Trade Price |
Trade Size |
Trade Value |
Trade Type |
| 07:12:34 | 10.50 | 10,000 | 1,050.00 | O |
| 07:12:32 | 10.00 | 10,000 | 1,000.00 | O |
| 07:12:20 | 10.00 | 10,000 | 1,000.00 | O |
| 2022-06-29 10:54:57 | 10.51 | 1,000 | 105.10 | O |
| Date | Subject |
|---|
30/6/2022
09:20 | Diurnal Daily Update: Diurnal Group Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker DNL. The last closing price for Diurnal was 10.75p.
Diurnal Group Plc has a 4 week average price of 10.63p and a 12 week average price of 10.63p.
The 1 year high share price is 66.50p while the 1 year low share price is currently 10.63p.
There are currently 169,320,105 shares in issue and the average daily traded volume is 9,945 shares. The market capitalisation of Diurnal Group Plc is £18,201,911.29.
|
29/6/2022
07:54 | best1467: Could be interesting are Eton lining up a bid for DNL THEY HAVE JUST SOLD RECEIVED $50 Million from sale to India’s DR REddy to solely focus on Rare disease portfolios.
|
27/6/2022
08:43 | c3479z: after dddd, it must be worrying for Dnl whether they can raise capital?
|
01/6/2022
14:12 | simon_64: LOL1 DB.
I am considering picking up a few at this price.
I will see what RBD does in June before i make up my mind sitting on huge paper loss here at present like many others.
|
20/4/2022
08:44 | daveboy19: Really annoying. Every single minute negative pounced upon and price pummeled, then a positive gets minimal attention. Tell me it's not manipulated and these are not in on it. Loads of shares sold at much higher prices and pi's left holding the baby as usual.
|
20/4/2022
08:14 | glasswala: Markets not interested in DNL
|
12/4/2022
15:18 | best1467: Well I’m of the option that with the current Mcap a takeover approach must be a distinct possibility and as mentioned above in is previous position he over saw several acquisitions at Horizon pharma would make perfect sense for Elton to acquire DNL
|
12/4/2022
10:40 | daveboy19: Yes, I was thinking the same. Eton is a 'partner' of DNL, but what this will do for our slaughtered share price is anyone's guess.
|
12/4/2022
08:12 | vino: Best
Pls could you clarify what Mr Gruber has to do with DNL as you must be reading info I can’t see
Thanks
|
05/4/2022
07:58 | wololol: For existing investors the share price has killed all sentiment. As a new investor I can't see why the WPhas droped so much. They have growing revenues , several assets at late stage development and a bug chunk of cash in the bank. The previous fund raises were not significantly discounted and they have stated next funding may not be dilutive. I don't expect them to raise money within a year and by that point the share price should be much higher. Therefore i am building a position pretty much at all time lows with so much news flow due this year.
|
04/4/2022
08:04 | weatherman: DNL looks like a takeover target now - good assets at reduced price and no CEO.
|
Diurnal share price data is direct from the London Stock Exchange
PLUS1
TRADING UPDATES: Indivior, Diurnal start trials; Alien Metals tests